Positions

Overview

  • Dr. Wick began his academic career in the School of Chemical Engineering at the Georgia Institute of Technology, where he developed internationally recognized research programs in cell adhesion and tissue engineering. He served as director of the Interdisciplinary Bioengineering Graduate Program from 2004 to 2005. He was recruited to UAB as Chair of the BME Department and co-director of UAB’s BioMatrix Engineering and Regenerative Medicine (BERM) Research Center in 2005. In 2015, he was appointed Senior Associate Dean of Engineering at UAB.

    Dr. Wick has more than 29 years of experience developing, evaluating, and validating biomedical engineering systems and devices to solve health-related problems and improve healthcare technology to benefit society. He has managed several million dollars of research funds from NIH, other government agencies, industry, and philanthropic foundations to develop physiologically relevant microvascular flow models to study cell adhesion, to develop 3-D human tissue constructs and bioreactors for tissue engineering and to develop novel transdermal drug delivery technologies. He has successfully mentored more than twenty-five master’s and Ph.D. students and more than 30 undergraduate honors students and research scholars. Dr. Wick has received the Lilly Foundation Teaching Fellowship, Outstanding Chemical Engineering Professor, and the UAB Graduate Dean’s Award for Excellence in Mentoring.

    Dr. Wick provides valuable leadership to develop innovative and interdisciplinary undergraduate and graduate degree programs, certificate programs, and student training. As director of the Interdisciplinary Engineering Ph.D. program, he works with faculty in engineering and across UAB to develop individualized interdisciplinary doctoral training programs to enable students to meet career goals in industry or academia. In summer 2015, Dr. Wick started Project Lab with several colleagues as an organized extracurricular to provide students from engineering, arts, sciences, and business interested in product design and development opportunities to innovate and develop engineering solutions to client problems. In Project Lab, students are trained in product design and development, innovation, teamwork, engineering validation, project documentation and marketing. To date, students have delivered more than 10 devices or apps that improve medical simulation and training, improve access for disabled persons, facilitate hearing loss prevention training, and assist patient rehabilitation.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2017 Temperature-responsive nanogel multilayers of poly(N-vinylcaprolactam) for topical drug deliveryJournal of Colloid and Interface Science.  506:589-602. 2017
    2017 Bone regeneration from human mesenchymal stem cells on porous hydroxyapatite-PLGA-collagen bioactive polymer scaffoldsBio-Medical Materials and Engineering.  28:671-685. 2017
    2016 Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogelsInternational Journal of Pharmaceutics.  509:465-476. 2016
    2016 Mechanical properties and osteogenic potential of hydroxyapatite-PLGA-collagen biomaterial for bone regenerationJournal of Biomaterials Science, Polymer Edition.  27:1139-1154. 2016
    2016 Exercise Medicine for Osteoarthritis: Research Strategies to Maximize EffectivenessArthritis Care and Research.  68:288-291. 2016
    2015 Transient Growth Factor Stimulation Improves Chondrogenesis in Static Culture and Under Dynamic Conditions in a Novel Shear and Perfusion BioreactorCellular and Molecular Bioengineering.  8:267-277. 2015
    2015 Transient Growth Factor Stimulation Improves Chondrogenesis in Static Culture and Under Dynamic Conditions in a Novel Shear and Perfusion BioreactorCellular and Molecular Bioengineering2015
    2015 Novel synthesis and characterization of a collagen-based biopolymer initiated by hydroxyapatite nanoparticlesActa Biomaterialia.  15:181-190. 2015
    2014 Novel synthesis and characterization of a collagen-based biopolymer initiated by hydroxyapatite nanoparticlesActa Biomaterialia2014
    2014 Evaluation of the effect of expansion and shear stress on a self-assembled endothelium mimicking nanomatrix coating for drug eluting stents in vitro and in vivoBiofabrication.  6. 2014
    2010 A new animal model for assessing cartilage repair and regeneration at a nonarticular siteTissue Engineering: Parts A, B, and C.  16:2321-2330. 2010
    2009 Protocol Development for Vitrification of Tissue-Engineered Cartilage.Bioprocessing Journal.  8:29-36. 2009
    2008 Hemodynamics and inflammatory mediators regulate sickle erythrocyte adhesion to endothelial cellsBiorheology.  45:62-62. 2008
    2006 Histamine increases sickle erythrocyte adherence to endotheliumBritish Journal of Haematology.  132:512-522. 2006
    2005 Endothelial cell-smooth muscle cell co-culture in a perfusion bioreactor systemAnnals of Biomedical Engineering.  33:920-928. 2005
    2004 Sickle cell adhesion depends on hemodynamics and endothelial activationJournal of Laboratory and Clinical Medicine.  144:260-267. 2004
    2004 Effect of low oxygen tension on tissue-engineered cartilage construct development in the concentric cylinder bioreactorTissue Engineering -Larchmont-.  10:825-832. 2004
    2004 Perfusion bioreactor for small diameter tissue-engineered arteriesTissue Engineering -Larchmont-.  10:930-941. 2004
    2003 Elevated endothelial cAMP reduces cell adhesion molecule expression on and sickle erythrocyte adhesion to TNF-alpha stimulated human dermal microvascular endothelium.Blood.  102:82A-82A. 2003
    2003 Histamine promotes sickle erythrocyte adherence to endothelium under flow through stimulation of H-2 and H-4 via nitric oxide synthase signaling.Blood.  102:259A-259A. 2003
    2003 Shear stress modulation of cytokine-induced sickle cell adherence to endothelium.Blood.  102:264A-264A. 2003
    2003 Inflammatory mediators promote strong sickle cell adherence to endothelium under venular flow conditionsAmerican Journal of Hematology.  73:215-224. 2003
    2003 Concentric cylinder bioreactor for production of tissue engineered cartilage: Effect of seeding density and hydrodynamic loading on construct developmentBiotechnology Progress.  19:510-521. 2003
    2002 Microcirculatory effects of Poloxamer 188 in transgenic sickle cell mice.Blood.  100:664A-664A. 2002
    2002 Sickle erythrocyte adherence to endothelium at low shear: Role of shear stress in propagation of vaso-occlusionAmerican Journal of Hematology.  70:216-227. 2002
    2002 Computational fluid dynamics modeling of steady-state momentum and mass transport in a bioreactor for cartilage tissue engineeringBiotechnology Progress.  18:951-963. 2002
    2001 Transgenic mice expressing exclusively HbS are more susceptible to endotoxin and desmopressin challenge.Blood.  98:488A-488A. 2001
    2001 Bioreactor for the scalable production of engineered cartilage construcs.ACS National Meeting Book of Abstracts.  221:U146-U146. 2001
    2001 Characterization of the mechanical and chemical environment in a cartilage bioreactor using computational fluid dynamics.ACS National Meeting Book of Abstracts.  221:U145-U146. 2001
    2001 Activation of vascular endothelial cell adhesion molecule expression by sickle blood cellsPediatric Pathology and Molecular Medicine.  20:47-72. 2001
    2000 Computational modeling of transport processes in a bioreactor for the production of engineered cartilageAnnals of Biomedical Engineering.  28. 2000
    2000 Optimizing bioreactor operating conditions for the production of engineered cartilageAnnals of Biomedical Engineering.  28. 2000
    2000 Sickle red blood cell adherence to endothelium is stronger for attachment under dynamic shear flowAnnals of Biomedical Engineering.  28. 2000
    2000 Microcirculatory effects of blocking cell adhesion molecules in transgenic sickle cell mice.Blood.  96:528A-528A. 2000
    2000 Microcirculatory effects of blocking cell adhesion molecules in transgenic sickle cell mice.Circulation.  102:307-307. 2000
    1999 Bioreactor for development of tissue engineered cartilage constructsAmerican Society of Mechanical Engineers, Bioengineering Division (Publication) BED.  42:131-132. 1999
    1999 Effect of shear stresses on cardiac leaflet fibroblastsAmerican Society of Mechanical Engineers, Bioengineering Division (Publication) BED.  42:205-206. 1999
    1999 Screening of antisickling agents by the new systematic multi-level analysis protocol developed at the sickle cell disease reference laboratory.Blood.  94:199A-199A. 1999
    1999 Sickle red blood cell (SRBC) adherence to endothelial cells (EC) is regulated by hemodynamics and receptor affinity.Blood.  94:675A-675A. 1999
    1998 Effect of fluid-mechanical and chemical environments on cell function and tissue growth: Experimental and modeling studiesAmerican Society of Mechanical Engineerings, Bioengineering Division (Publication) BED.  40:55-59. 1998
    1998 Short report: Plasmodium falciparum: Cytoadherence to α(v)β3 on human microvascular endothelial cellsAmerican Journal of Tropical Medicine and Hygiene.  59:77-79. 1998
    1998 Prosthesis-induced hemolysis: Mechanisms and quantification of shear stressJournal of Heart Valve Disease.  7:376-386. 1998
    1998 Endothelial cells in physiology and in the pathophysiology of vascular disordersBlood.  91:3527-3561. 1998
    1998 RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxinAnnals of the New York Academy of Sciences.  850:391-393. 1998
    1997 Flow chamber to mimic the environment in artificial heart valves effect of shear stress on fibroblastsAmerican Society of Mechanical Engineerings, Bioengineering Division (Publication) BED.  35:195-196. 1997
    1997 Erythrocyte adhesion to cremaster endotheilum in mice with abnormal hemoglobin is increased by topical endotoxin.Blood.  90:1960-1960. 1997
    1997 Plasmodium falciparum: Soluble thrombospondin increases cytoadherence of parasitized erythrocytes to human microvascular endothelium under shear flow conditionsExperimental Parasitology.  87:69-72. 1997
    1996 Hemodynamic modulation of monocytic cell adherence to vascular endotheliumAnnals of Biomedical Engineering.  24:382-393. 1996
    1996 Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: A novel pathway involving α4β1integrin receptors on sickle reticulocytes and fibronectinBlood.  88:4348-4358. 1996
    1996 Continuous recirculating contact enhances adhesion of sickle red blood cells to endothelial cells.Blood.  88:27-27. 1996
    1996 Inhibition of plasma-mediated sickle erythrocyte adherence to microvascular endothelium by poloxamer compounds.Blood.  88:24-24. 1996
    1996 Sickle red blood cell adherence to vascular endothelium is more tenacious in confined flow channelsBlood.  88:23-23. 1996
    1996 Tenacity of sickle red blood cell (SRBC) endothelial cell (EC) adherence is augmented under hemodynamic shear and by involvement of multiple adhesion pathways.Blood.  88:2585-2585. 1996
    1996 Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptidesAmerican Journal of Hematology.  53:92-98. 1996
    1996 A novel method for quantification of surgical gown permeabilityASTM Special Technical Publication.  1237:123-130. 1996
    1996 Molecular basis of sickle cell-endothelial cell interactionsCurrent opinion in hematology.  3:118-124. 1996
    1995 Increased tenacity of sickle erythrocyte-endothelial cell adherence by involvement of multiple receptor-ligand interactionsBlood.  86:1180-1180. 1995
    1995 PHORBOL ESTER ACTIVATION OF ALPHA(4)BETA(1) INTEGRINS ON SICKLE RETICULOCYTES INCREASES RED-CELL ADHERENCE TO ENDOTHELIUMFederation proceedings.  9:A846-A846. 1995
    1995 DUAL MODULATION OF MONOCYTE ADHERENCE TO VASCULAR ENDOTHELIUM BY SHEAR-STRESSFederation proceedings.  9:A35-A35. 1995
    1995 INDUCTION OF ENDOTHELIAL ADHESION MOLECULE EXPRESSION BY SICKLE CELLS - A POSSIBLE MECHANISM FOR INCREASED BY VASCULAR-DISEASEFederation proceedings.  9:A541-A541. 1995
    1995 Double-stranded RNA induces sickle erythrocyte adherence to endothelium: A potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemiaBlood.  85:2945-2950. 1995
    1994 IN-VITRO COMPARISON OF KNOWN MECHANISMS OF SICKLE ERYTHROCYTE ADHERENCE TO ENDOTHELIUM - BIOPHYSICAL STUDIES TO PREDICT THE RELATIVE IMPORTANCE OF COMPETING ADHERENCE PATHWAYS IN-VIVOBlood.  84:A407-A407. 1994
    1994 SHORT-TERM CONTACT WITH SICKLE ERYTHROCYTES INHIBITS SHEAR-INDUCED ELONGATION OF ARTERIAL ENDOTHELIUMBlood.  84:A407-A407. 1994
    1994 SICKLE ERYTHROCYTES STIMULATED WITH PHORBOL ESTER ADHERE TO ENDOTHELIUM VIA ACTIVATED ALPHA-4-BETA-1 INTEGRIN ON SICKLE RETICULOCYTES AND FIBRONECTIN ON ENDOTHELIUMBlood.  84:A408-A408. 1994
    1994 INCREASED MONOCYTE ADHERENCE TO ENDOTHELIAL-CELLS (ECS) EXPOSED TO LOW SHEAR-STRESS IS VIA A VCAM-1/ALPHA-4-BETA-1 MEDIATED MECHANISMFederation proceedings.  8:A322-A322. 1994
    1993 PLASMA ENHANCEMENT OF SICKLE RED-BLOOD-CELL (RBC) ADHERENCE TO MICROVASCULAR ENDOTHELIAL-CELLS (MEC) MEDIATED BY INTEGRIN RECEPTORS CAN BE INHIBITED BY CONFORMATIONALLY CONSTRAINED RGD PEPTIDESBlood.  82:A353-A353. 1993
    1993 SICKLE RED-BLOOD-CELLS (RBC) INDUCE EXPRESSION OF CELL-ADHESION MOLECULES ON HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS (HUVEC)Blood.  82:A352-A352. 1993
    1993 STIMULATION OF SICKLE ERYTHROCYTES WITH PHORBOL ESTER PROMOTES ADHERENCE TO ENDOTHELIUM - A POTENTIAL ROLE FOR ACTIVATED VLA-4 (ALPHA-4-BETA-1) ON SICKLE RETICULOCYTESBlood.  82:A352-A352. 1993
    1993 SYNTHETIC DOUBLE-STRANDED-RNA INCREASES ADHERENCE OF SICKLE RED-BLOOD-CELLS (SRBC) TO HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS (HUVEC) VIA ALPHA-4-BETA-1 - VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) PATHWAYBlood.  82:A352-A352. 1993
    1993 Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusionBlood.  81:2137-2143. 1993
    1993 SICKLE RETICULOCYTES EXPRESS CD36 AND ALPHA-4-BETA-1 WHICH MEDIATE THEIR BINDING TO ENDOTHELIAL-CELLSClinical research.  41:A262-A262. 1993
    1993 Cytoadherence of plasmodium falciparum-infected erythrocytes to microvascular endothelium is regulatable by cytokines and phorbol esterJournal of Infectious Diseases.  167:698-703. 1993
    1993 Prolonged contact wild blood alters surgical gown permeabilityAmerican Journal of Infection Control.  21:249-256. 1993
    1993 Unusually large von willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cellsAmerican Journal of Hematology.  42:284-292. 1993
    1993 α4β1-Integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endotheliumBlood.  82:1891-1899. 1993
    1992 CYTOADHERENCE OF PLASMODIUM-FALCIPARUM PARASITIZED RED-BLOOD-CELLS (PRBC) TO HUMAN MICROVASCULAR ENDOTHELIAL-CELL (MEC) CD36 AND ICAM-1 IS STRAIN-SPECIFIC AND REGULATABLEFederation proceedings.  6:A1892-A1892. 1992
    1992 Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitroJournal of Immunology.  148:78-83. 1992
    1992 Plasmodium fragile: Cytoadherence of parasitized rhesus monkey erythrocytes to human endothelial cells under shear flow conditionsExperimental Parasitology.  74:228-231. 1992
    1992 Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively differentJournal of Laboratory and Clinical Medicine.  120:538-545. 1992
    1991 Abnormal adhesion of sickle red blood cells to human microvascular endothelial cells. A potential role for the plasma milieu in the initiation of vaso-occlusion in sickle cell diseaseAnnals of Biomedical Engineering.  19:580. 1991
    1991 Blood permeability of non-woven surgical gownsAnnals of Biomedical Engineering.  19:605. 1991
    1991 ABNORMAL ADHESION OF SICKLE ERYTHROCYTES TO HUMAN MICROVASCULAR ENDOTHELIAL-CELLS IS DUE TO RED-CELL FACTORS AND COLLAGEN-BINDING PLASMA-PROTEINSFederation proceedings.  5:A528-A528. 1991
    1991 Cytoadherence of Plasmodium falciparum-infected erythrocytes to human umbilical vein and human dermal microvascular endothelial cells under shear conditionsAmerican Journal of Tropical Medicine and Hygiene.  45:578-586. 1991
    1987 Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flowJournal of Clinical Investigation.  80:905-910. 1987

    Research Overview

  • Dr. Wick's major contributions to vascular biology, tissue engineering, and drug delivery are in the following areas:

    -identification of mechanisms of sickle red blood cell adherence to endothelium and its role in pathophysiology of sickle cell anemia;
    -orthopaedic and cardiac tissue engineering and bioreactor design; and
    -design of controlled release systems to enhance transdermal drug delivery.

    Dr. Wick’s early research was directed at understanding the role of red blood cell adhesion in the pathophysiology of sickle cell anemia. Using flow chambers and physiologically relevant models of microvascular blood flow to measure kinetics and strength of sickle red blood cell adherence to human endothelial cells under microvascular flow conditions, his group identified cell adhesion receptors on sickle red blood cells and demonstrated that sickle red cells bind to endothelial cells via specific receptor-mediated interactions. These mechanistic studies identified a novel role for sickle red blood cell adhesion to endothelium as a potential contributing factor to sickle cell vaso-occlusive pain episodes that contributed to development of anti-adhesion therapies for sickle cell anemia.

    The goal of Dr. Wick’s tissue engineering research is to develop 3-D tissue constructs, bioreactors and bioprocessing technologies to repair or replace diseased or damaged organs. His group uses novel biomaterials as scaffolds for cells to proliferate and mature into functional 3D tissue constructs. They have developed and validated bioreactors that provide spatially correct delivery of mechanical forces and nutrient transport to fabricate musculoskeletal and cardiovascular tissue constructs under well-defined controllable conditions. The Wick lab recently fabricated a multicomponent osteoinductive biomaterial that shows promise for bone regeneration from pluripotent stem cells. Their bioreactors are scalable and can be integrated with robotic and process technologies for large-scale tissue production.

    A recent collaboration between UAB and Southern Research aims to enhance transdermal delivery of NSAIDs to treat joint pain associated with osteoarthritis. The technology developed integrates diclofenac sodium into a wearable bandage that provides rapid and sustained delivery of therapeutic levels of drug is an attractive alternative to topical application using a gel or solution. Future iterations of the device can include transport of other therapeutics (e.g. corticosteroids) and novel therapeutics for arthritis and related musculoskeletal conditions.
  • Teaching Activities

  • EGR481 - Interdisciplinary Project Lab (Fall Term 2018) 2018
  • HC111 - Honors Seminar in Engineering (Fall Term 2018) 2018
  • EGR481 - Interdisciplinary Project Lab (Summer Term 2018) 2018
  • EGR301 - Honors Research I (Fall Term 2017) 2017
  • HC111 - Honors Seminar in Engineering (Fall Term 2017) 2017
  • EGR490 - Special Topics in (Area) (Summer Term 2017) 2017
  • BME490 - Special Topic in BME (Fall Term 2016) 2016
  • EGR301 - Honors Research I (Fall Term 2016) 2016
  • EGR490 - Special Topics in (Area) (Fall Term 2016) 2016
  • HC111 - Honors Seminar in Engineering (Fall Term 2016) 2016
  • BME799 - Dissertation Research (Spring Term 2016) 2016
  • BME490 - Special Topic in BME (Fall Term 2015) 2015
  • BME799 - Dissertation Research (Fall Term 2015) 2015
  • HC111 - Honors Seminar in Engineering (Fall Term 2015) 2015
  • BME799 - Dissertation Research (Summer Term 2015) 2015
  • BME350 - Biological Transport Phenomena (Spring Term 2015) 2015
  • BME491 - Individual Study in BME (Spring Term 2015) 2015
  • BME799 - Dissertation Research (Spring Term 2015) 2015
  • BME408 - Biofluids (Fall Term 2014) 2014
  • BME491 - Individual Study in BME (Fall Term 2014) 2014
  • BME495 - Honors Research II (Fall Term 2014) 2014
  • BME508 - Biofluids (Fall Term 2014) 2014
  • BME799 - Dissertation Research (Fall Term 2014) 2014
  • BME798 - Non-Dissertation Research (Summer Term 2014) 2014
  • BME799 - Dissertation Research (Summer Term 2014) 2014
  • BME350 - Biological Transport Phenomena (Spring Term 2014) 2014
  • BME494 - Honors Research I (Spring Term 2014) 2014
  • BME798 - Non-Dissertation Research (Spring Term 2014) 2014
  • BME698 - Non-Thesis Research (Fall Term 2013) 2013
  • BME798 - Non-Dissertation Research (Fall Term 2013) 2013
  • BME798 - Non-Dissertation Research (Summer Term 2013) 2013
  • BME350 - Biological Transport Phenomena (Spring Term 2013) 2013
  • BME495 - Honors Research II (Spring Term 2013) 2013
  • BME798 - Non-Dissertation Research (Spring Term 2013) 2013
  • BME495 - Honors Research II (Fall Term 2012) 2012
  • BME798 - Non-Dissertation Research (Fall Term 2012) 2012
  • BME799 - Dissertation Research (Fall Term 2012) 2012
  • BME494 - Honors Research I (Summer Term 2012) 2012
  • BME698 - Non-Thesis Research (Summer Term 2012) 2012
  • BME799 - Dissertation Research (Summer Term 2012) 2012
  • BME350 - Biological Transport Phenomena (Spring Term 2012) 2012
  • BME494 - Honors Research I (Spring Term 2012) 2012
  • BME798 - Non-Dissertation Research (Spring Term 2012) 2012
  • BME698 - Non-Thesis Research (Fall Term 2011) 2011
  • BME798 - Non-Dissertation Research (Fall Term 2011) 2011
  • BME798 - Non-Dissertation Research (Summer Term 2011) 2011
  • BME350 - Biological Transport Phenomena (Spring Term 2011) 2011
  • BME491 - Individual Study in (Area) (Spring Term 2011) 2011
  • BME690 - Special Topics in (Area) (Spring Term 2011) 2011
  • BME798 - Non-Dissertation Research (Spring Term 2011) 2011
  • BME401 - Undergraduate BME Seminar (Fall Term 2010) 2010
  • BME496 - BME Honors Seminar (Fall Term 2010) 2010
  • BME601 - Biomedical Engineering Seminar (Fall Term 2010) 2010
  • BME698 - Non-Thesis Research (Fall Term 2010) 2010
  • BME701 - Biomedical Engineering Seminar (Fall Term 2010) 2010
  • BME798 - Non-Dissertation Research (Fall Term 2010) 2010
  • BME495 - Honors Research II (Summer Term 2010) 2010
  • BME699 - Masters Thesis Research (Summer Term 2010) 2010
  • BME798 - Non-Dissertation Research (Summer Term 2010) 2010
  • BME011 - UG Coop/Intership in BME (Spring Term 2010) 2010
  • BME350 - Biological Transport Phenomena (Spring Term 2010) 2010
  • BME401 - Undergraduate BME Seminar (Spring Term 2010) 2010
  • BME495 - Honors Research II (Spring Term 2010) 2010
  • BME496 - BME Honors Seminar (Spring Term 2010) 2010
  • BME601 - Biomedical Engineering Seminar (Spring Term 2010) 2010
  • BME699 - Masters Thesis Research (Spring Term 2010) 2010
  • BME701 - Biomedical Engineering Seminar (Spring Term 2010) 2010
  • BME401 - Undergraduate BME Seminar (Fall Term 2009) 2009
  • BME495 - Honors Research II (Fall Term 2009) 2009
  • BME496 - BME Honors Seminar (Fall Term 2009) 2009
  • BME601 - Biomedical Engineering Seminar (Fall Term 2009) 2009
  • BME698 - Non-Thesis Research (Fall Term 2009) 2009
  • BME699 - Masters Thesis Research (Fall Term 2009) 2009
  • BME701 - Biomedical Engineering Seminar (Fall Term 2009) 2009
  • BME798 - Non-Dissertation Research (Fall Term 2009) 2009
  • BME494 - Honors Research I (Summer Term 2009) 2009
  • BME698 - Non-Thesis Research (Summer Term 2009) 2009
  • BME699 - Masters Thesis Research (Summer Term 2009) 2009
  • BME401 - Undergraduate BME Seminar (Spring Term 2009) 2009
  • BME496 - BME Honors Seminar (Spring Term 2009) 2009
  • BME601 - Biomedical Engineering Seminar (Spring Term 2009) 2009
  • BME691 - Individual Study in (Area) (Spring Term 2009) 2009
  • BME698 - Non-Thesis Research (Spring Term 2009) 2009
  • BME701 - Biomedical Engineering Seminar (Spring Term 2009) 2009
  • BME494 - Honors Research I (Fall Term 2008) 2008
  • BME698 - Non-Thesis Research (Fall Term 2008) 2008
  • BME699 - Masters Thesis Research (Fall Term 2008) 2008
  • BME698 - Non-Thesis Research (Summer Term 2008) 2008
  • BME699 - Masters Thesis Research (Summer Term 2008) 2008
  • BME401 - Undergraduate BME Seminar (Spring Term 2008) 2008
  • BME496 - BME Honors Seminar (Spring Term 2008) 2008
  • BME601 - Biomedical Engineering Seminar (Spring Term 2008) 2008
  • BME698 - Non-Thesis Research (Spring Term 2008) 2008
  • BME701 - Biomedical Engineering Seminar (Spring Term 2008) 2008
  • BME350 - Biological Transport Phenomena (Fall Term 2007) 2007
  • BME401 - Undergraduate BME Seminar (Fall Term 2007) 2007
  • BME496 - BME Honors Seminar (Fall Term 2007) 2007
  • BME601 - Biomedical Engineering Seminar (Fall Term 2007) 2007
  • BME698 - Non-Thesis Research (Fall Term 2007) 2007
  • BME701 - Biomedical Engineering Seminar (Fall Term 2007) 2007
  • Education And Training

  • Doctor of Philosophy in Chemical Engineering, Rice University 1988
  • Full Name

  • Timothy Wick
  • Fax

  • 205-934-8437